In the United States Court of Federal Claims
OFFICE OF SPECIAL MASTERS
No. 19-403V
UNPUBLISHED
JENNIFER ANDERSON, Chief Special Master Corcoran
Petitioner, Filed: January 27, 2021
v.
Special Processing Unit (SPU);
SECRETARY OF HEALTH AND Dismissal; Untimely Filed; Lookback
HUMAN SERVICES, Provision; Influenza (Flu) Vaccine;
Guillain-Barre Syndrome (GBS)
Respondent.
Lawrence R. Cohan, Saltz Mongeluzzi & Bendesky, Philadelphia, PA, for petitioner.
Mark Kim Hellie, U.S. Department of Justice, Washington, DC, for respondent.
DECISION1
On March 15, 2019, Jennifer Anderson filed a petition for compensation under the
National Vaccine Injury Compensation Program, 42 U.S.C. §300aa-10, et seq.2 (the
“Vaccine Act”). Petitioner alleged that she suffered Guillain-Barre Syndrome (“GBS”) as
a result of an influenza (“flu”) vaccine administered on October 2, 2014. The matter was
assigned to the Special Processing Unit of the Office of Special Masters.
On July 2, 2020, Respondent filed a combined Rule 4(c) Report and Motion to
Dismiss (“Mot.”). ECF No. 26. Respondent asserted that Petitioner’s claim should be
dismissed because it was time-barred under the Vaccine Act. Ms. Anderson filed a
response (“Resp.”) on August 17, 2020, in which she maintained that her claim was timely
1 Because this unpublished ruling contains a reasoned explanation for the action in this case, I am required
to post it on the United States Court of Federal Claims' website in accordance with the E-Government Act
of 2002. 44 U.S.C. § 3501 note (2012) (Federal Management and Promotion of Electronic Government
Services). This means the ruling will be available to anyone with access to the internet. In accordance
with Vaccine Rule 18(b), Petitioner has 14 days to identify and move to redact medical or other information,
the disclosure of which would constitute an unwarranted invasion of privacy. If, upon review, I agree that
the identified material fits within this definition, I will redact such material from public access.
2National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755. Hereinafter, for ease
of citation, all section references to the Vaccine Act will be to the pertinent subparagraph of 42 U.S.C. §
300aa (2012).
under the Act’s “lookback” provision, even if she could not meet the onset requirements
for a Table flu-GBS claim. ECF No. 28.
Having reviewed the parties’ filings, I find that dismissal is warranted. Petitioner’s
claim was filed over four years from the alleged onset date of her injury – well outside
the Act’s 36-month statute of limitations – and Petitioner concedes that she cannot
establish the Table requirements of a flu-GBS injury. Under these circumstances, the
“lookback” provision of the Act does not save Petitioner’s claim for purposes of the statute
of limitations, and it must therefore be dismissed as untimely.
PROCEDURAL HISTORY
Petitioner initiated this case on March 15, 2019, alleging that she suffered GBS as
a result of a flu vaccine administered in “late October 2014.” Petition at ¶ 3. In the Petition,
Ms. Anderson alleged that she began experiencing lower extremity tingling symptoms on
November 14, 2014, and that her symptoms worsened thereafter. Id. at ¶ 4. She
confirmed that she would subsequently move for subpoena authority to obtain records
and consent forms in connection with her vaccination. Id. at 2 n.1. Petitioner did so later
that month,3 and an order was issued on April 4, 2019 authorizing Petitioner to serve a
subpoena on the University of St. Thomas Health Services, the vaccine administrator.
ECF Nos. 8, 10. Petitioner thereafter filed the vaccination records collected pursuant to
subpoena (which confirmed the subject vaccine was administered on October 2, 2014)
and an affidavit. ECF No. 11. Petitioner filed a Statement of Completion on May 7, 2019.
ECF No. 12.
Following the initial status conference held on July 11, 2019, Petitioner filed
additional medical records and an amended Statement of Completion. ECF Nos. 16-18.
On April 30, 2020, Respondent filed a status report confirming he had reviewed the
available records and intended to defend this case. ECF No. 25.
On July 2, 2020, Respondent filed a combined Rule 4(c) Report and Motion to
Dismiss. Respondent asserted that Petitioner could not preponderantly establish a
presumptive GBS injury under the Vaccine Injury Table, because the onset of her
symptoms occurred 43 days after the October 2, 2014 vaccination – a day outside the
prescribed 3-42 day Table onset period. Mot. at 9-10. Indeed, Respondent noted that
Petitioner herself alleged that her symptoms began 43 days following vaccination, and
the medical records were corroborative of this timeline. Id.
Given the above, Respondent argued that the Petition should be dismissed
because Ms. Anderson could not otherwise maintain an off-Table, causation-in-fact claim
3Prior to filing her motion for subpoena authority, Petitioner filed medical records on March 18, 2019. Exs.
1-4 (ECF No. 4).
2
using the “lookback” provision of the Vaccine Act. Id. at 10. In support, Respondent cited
my dismissal decision in Randolph v. Sec’y of Health & Human Servs., No. 18-1231V,
2020 WL 542735 (Fed. Cl. Spec. Mstr. Jan. 2, 2020). There, I declined to extend the Act’s
“lookback” provision to off-Table GBS claims that were based on non-viable Table claims
that themselves were untimely but would otherwise be saved by the “lookback” provision.
Randolph, 2020 WL 542735, at *9-12.
Ms. Anderson’s responsive brief confirmed that she did not contest that her
symptoms began 43 days after vaccination – thus conceding that her claim could not
meet the Table requirements for a presumptive GBS injury. Resp. at 2, 5. Nevertheless,
Petitioner asserted that because she was advancing a legally valid non-Table claim
(unlike the petitioner in Randolph), the “lookback” provision saved her otherwise untimely
claim for purposes of the statute of limitations. Id. at 10-12.
In reply to the above, Respondent argued that the Randolph decision dismissing
the claim was a legal determination made independent of the facts. Reply at 2 (ECF No.
29). Although Respondent acknowledged that Randolph discussed the merits of the
potential non-Table claim, he explained that this discussion had no bearing on the
ultimate disposition of the case. Id. Instead, Respondent asserted that the non-Table
claim in Randolph was dismissed because it was time-barred as a matter of law. Id.
This case is now ripe for a determination.
ANALYSIS
I. Petitioner Cannot Establish a Successful Table Flu-GBS Claim
Ms. Anderson has conceded that the onset of her GBS symptoms occurred 43
days after vaccination – outside the prescribed Table onset period.4 I will nevertheless
briefly discuss the onset of Petitioner’s GBS before turning to her arguments regarding
the applicability of the “lookback” provision to this case.5
As a general matter, to receive compensation under the Program, a petitioner must
prove either 1) that she suffered a “Table Injury” – i.e., an injury falling within the Vaccine
4 Ms. Anderson alleged in the Petition that she began experiencing tingling symptoms on November 14,
2014. See Petition at ¶ 4 (citing Petitioner’s January 10, 2015 medical appointment with Dr. Schriefer). And
in her brief responding to the Motion to Dismiss, Petitioner reiterated that her “GBS symptoms began on
November 14, 2014 when she experienced tingling in her left foot.” Resp. at 2, 5.
5 I have reviewed all the records filed to date. A more complete recitation of the facts can be found in the
Petition, the parties’ respective briefs, and in Respondent’s Rule 4(c) Report. Given the issues involved in
this decision, I have limited my discussion to the records most relevant to the onset of Petitioner’s GBS
injury.
3
Injury Table – corresponding to one of her vaccinations, or 2) that she suffered an injury
that was actually caused by a vaccine. See Sections 11(c)(1) and 13(a)(1)(A). Under the
Vaccine Act, a petitioner may not be awarded compensation based on the petitioner’s
claims alone. Rather, the petition must be supported by either the medical records or by
a medical opinion. Section 13(a)(1).
The most recent version of the Table, which can be found at 42 C.F.R. § 100.3,
identifies the vaccines covered under the Program, the corresponding injuries, and the
time period in which the particular injuries must occur after vaccination. Pursuant to the
Vaccine Injury Table, GBS is compensable if it manifests within 3-42 days (not less than
three days and not more than 42 days) of the administration of a flu vaccination. 42 C.F.R.
§ 100.3(a)(XIV)(D).
The record plainly demonstrates that Petitioner’s GBS symptoms manifested
outside the Table-mandated timeframe. On October 2, 2014, Petitioner was administered
a flu vaccine at the University of St. Thomas Health Services as a condition of her
employment. Ex. 6 at 2-3; Petition at ¶ 3. On December 3, 2014, Petitioner presented to
Robert G. Jacoby, M.D., at Noran Neurological Clinic, P.A. Petitioner noted that she had
been experiencing back and hip pain, but that a few days around her birthday (November
14) she began to notice numbness, tingling, and pain in her calves and lower back. Ex. 1
at 22.
On December 4, 2014, Petitioner completed a medical history form. Id. at 175. In
it, she indicated that her lower extremity numbness and weakness began on “11/14.” Id.
The next month, on January 10, 2015, Petitioner presented to Thomas Schriefer, M.D.,
for a neurological evaluation. Petitioner stated that, on the night of November 14, 2014 –
43 days following the October 2, 2014 vaccination – she noticed a tingling sensation in
her left foot and subsequently developed increasing pain, numbness, and weakness. Id.
at 56. Dr. Schriefer assessed Petitioner with a likely acute axonal motor variant of GBS.
Id. at 58.
All such facts preponderantly establish that Petitioner cannot meet the Table onset
requirements for a flu-GBS claim.
II. Petitioner’s Non-Table Claim is Time-Barred
A Vaccine Program claim that presents facts “close” to a Table claim’s
requirements (like a slightly too-long or too-short onset) might still succeed as a
causation-in-fact claim, and thus complete dismissal of a petition would not always be
merited even if the Table claim clearly could not be advanced. See, e.g., Greene v. Sec’y
of Health & Human Servs., No. 11-631V, 2015 WL 9056034 (Fed. Cl. Spec. Mstr. July
31, 2015) (dismissal of Table brachial neuritis claim for failure to meet onset timeframe,
4
while allowing non-Table version to proceed). But, as with any case, a Vaccine Act claim
must have been timely filed – meaning in most cases within three years/36 months of
manifestation of injury onset. Section 16(a)(2).
Here, Petitioner’s claim was filed over four years after the alleged November 2014
onset date of her injury, making it facially untimely. Ms. Anderson has nevertheless
argued that the “lookback” provision of the Vaccine Act (specifically Section 16(b)) saves
her non-Table claim. That provision is triggered by any Table revision, and allows
petitioners to file otherwise-untimely petitions within two years of the revision’s effective
date based upon vaccine-related injuries suffered during the eight years prior to the
revision. Section 16(b)(2). The lookback thus creates a somewhat shortened limitations
period for a narrow class of claims that might have otherwise accrued well prior to the
Table revision.
Does the lookback save the present claim? Certainly this case was initiated within
the temporal limits set by Section 16(b). Indeed, the Petition was filed on March 15, 2019
– within two years of the March 21, 2017 Table amendment to include a defined flu-GBS
claim.6 Petitioner furthermore alleges onset of her injury on November 14, 2014 – well
within the eight-year period preceding the amendment’s 2017 effective date.
However, as I have previously determined, Section 16(b) does not extend the time
to bring a claim that could have been asserted within the Act’s three-year limitations
period simply because the claim is “close” factually to what the Table amendment permits.
Randolph, 2020 WL 542735, at *8-12. Rather, it only properly governs otherwise-untimely
claims that fit the precise requirements of the Table revision (or that could not have been
otherwise asserted before the amendment – which is not the case here, as noted below).7
My determination on this issue is fully consistent with prior decisions from other special
masters. Gorski v. Sec’y of Health & Human Servs., No. 97-156V, 1997 WL 739497, at
*6 (Fed. Cl. Spec. Mstr. Nov. 13, 1997).
In her brief, Petitioner attempts to distinguish Randolph by noting that she only
intended to advance a “legally valid, non-Table injury claim” – and thus her inability to
meet the Table requirement is immaterial. Resp. at 10-12. She also maintains that a 43-
day onset falls within a “scientifically recognized time-span of when her influenza vaccine
6 Effective for petitions filed beginning on March 21, 2017, GBS was an injury listed on the Table. See
National Vaccine Injury Compensation Program: Revisions to the Vaccine Injury Table, Final Rule, 82 Fed.
Reg. 6294 (Jan. 19, 2017); National Vaccine Injury Compensation Program: Revisions to the Vaccine Injury
Table, Delay of Effective Date, 82 Fed. Reg. 11321 (Feb. 22, 2017) (delaying the effective date of the final
rule until March 21, 2017).
7 The lookback also means that cases invoking it as a limitations exception will be evaluated for their Table
viability despite their facial untimeliness (Randolph, 2020 WL 542735, at *11) – precisely what has
happened here, since my decision to dismiss based on the Act’s statute of limitations only follows the
determination that the claim cannot succeed as a Table claim congruent with the Table amendment.
5
could have caused her GBS symptoms,” and therefore has a nascent viability even
though she could not meet the Table onset requirements. Id. at 11.
I readily concede that a timely-filed, non-Table flu-GBS claim alleging a 43-day
onset could well succeed if supported by reliable evidence (particularly with respect to the
onset timeframe). Indeed, I have decided (rather than dismissing out of hand) non-Table
claims alleging onset falling outside of the Table’s requirements. See, e.g., Rowan v.
Sec'y of Health & Human Servs., No. 17-760V, 2020 WL 2954954 (Fed. Cl. Spec. Mstr.
Apr. 28, 2020) (addressing non-Table claim that the petitioner’s GBS began within 36
hours of vaccination). But as I stated in Randolph, Section 16(b) is not reasonably
interpreted so broadly, such that it greatly enlarges the limitations period for claims that
parallel a Table claim but cannot quite meet the claim’s Table requirements. Randolph,
2020 WL 542735, at *10-12. As a result, arguments that Petitioner’s claim might succeed
as a non-Table claim cannot get around the claim’s untimeliness – especially since claims
alleging a flu vaccine injury have been generally permitted under the Act for more than
15 years. Id. at *9.
CONCLUSION
Petitioner cannot offer preponderant evidence to establish a Table claim, rendering
the case untimely despite the operation of Section 16(b). Accordingly, for the reasons
described above, Respondent’s Motion to Dismiss is GRANTED, and this case is hereby
DISMISSED.8
IT IS SO ORDERED.
s/Brian H. Corcoran
Brian H. Corcoran
Chief Special Master
8 Pursuant to Vaccine Rule 11(a), entry of judgment can be expedited by the parties’ joint filing of notice
renouncing the right to seek review.
6